Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Iris Klewinghaus is active.

Publication


Featured researches published by Iris Klewinghaus.


Gene | 1991

A surface expression vector for antibody screening.

Frank Breitling; Stefan Dübel; Thomas Dr Seehaus; Iris Klewinghaus; Melvyn Little

To select specific antibodies (Ab) from large recombinant libraries using small amounts of antigen, we have constructed a phagemid that expresses a single-chain Ab fused to pIII, a coliphage protein product of gene III that initiates infection by binding to F pili. Surprisingly, the production of the fusion protein (Ab::pIII) was induced by wild-type (wt) phage fd in the absence of IPTG. Ab::pIII was identified by a monoclonal Ab to an epitope in the linker sequence between the heavy and light chains, and by antisera to their N-terminal sequences. It is able to bind antigen and be assembled into infectious phagemid particles that can be enriched on columns of immobilised antigen. The phagemid DNA is even smaller than that of wt fd phages and can easily be propagated in plasmid form. Most importantly, its Ab::pIII-encoding gene can be tightly repressed so that Ab libraries can be amplified without risk of being dominated by deletion mutants. After induction, however, large quantities of the fusion protein can be produced, thus greatly facilitating its analysis.


Gene | 1993

A family of vectors for surface display and production of antibodies.

Stefan Dübel; Frank Breitling; Patrick Fuchs; Michael Braunagel; Iris Klewinghaus; Melvyn Little

Expression vectors for surface display and production of single-chain (Fv) antibodies (scAb) have been constructed based on the phagemid pSEX, which expresses DNA encoding a scAb fused to the gene III product of filamentous phage [Breitling et al., Gene 104 (1991) 147-153]. A smaller version of this phagemid, pSEX20, was made by removing an unnecessary cat. To produce a vector for the surface display of other proteins and peptides, the scAb of pSEX20 was substituted by a polycloning site (MCS) to give pSEX40. For the presentation of Ab on the surface of Escherichia coli, phagemid pAP10 was derived from pSEX20 by substituting gene III with a gene encoding the peptidoglycan-associated lipoprotein (PAL). Vectors for producing scAb that can be purified by antibody and metal affinity chromatography were constructed by substituting gene III in the vector pSEX20 with DNA encoding a peptide with a C-terminal epitope recognised by a monoclonal antibody (phagemid pOPE40) or with five C-terminal histidines (pOPE 90).


Cell Biochemistry and Biophysics | 1992

Regulated secretion and purification of recombinant antibodies inE. coli

Stefan Dübel; Frank Breitling; Iris Klewinghaus; Melvyn Little

A plasmid foroptimizedproteinexpression of recombinant Fv antibodies (pOPE) inE. coli was used to express the variable domains of the murine monoclonal antibody HD39 specific for the human B-cell surface antigen CD22. The production of Fv antibodies by pOPE can be regulated over a wide range by varying the IPTG concentration. Antibodies that can discriminate between secreted and nonsecreted Fv antibody fragments were used to show that secretion is the limiting step for the production of functional Fv antibodies. IPTG concentrations above 20 μM increased the total antibody production, but did not yield larger amounts of secreted Fv antibodies. The addition of five histidines to the C terminus facilitates an easy single-step enrichment procedure based on immobilized metal affinity chromatography.


Cell Biochemistry and Biophysics | 1992

Recombinant human monoclonal antibodies: basic principles of the immune system transferred to E. coli

Patrick Fuchs; Stefan Dübel; Frank Breitling; Michael Braunagel; Iris Klewinghaus; Melvyn Little

To produce human monoclonal antibodies in bacteria, a gene repertoire of IgM variable regions was isolated from human peripheral B lymphocytes by the polymerase chain reaction. Alternatively, synthetic antibody genes with random hypervariable regions are being generated that may provide libraries of even higher complexity. For the selection of specific monoclonal antibodies from these libraries, we have developed twoE. coli vector systems that facilitate the surface display of an antibody physically linked to its own gene. The phagemid pSEX encodes a fusion protein of an antigen binding domain (Fv-antibody) with the docking protein (pIII) of filamentous phages. Specific antibody genes can therefore be enriched by antigen affinity chromatography. The plasmid pAP1 encodes a fusion protein of an Fv-antibody with a bacterial cell-wall protein. Bacteria carrying this plasmid express functional Fv-antibodies tightly bound to their surface. This should enable the selection of single cells with a fluorescence-assisted cell sorter (FACS) using labeled antigen or by adsorption to immobilized antigen.These vectors permit three major principles of the antibody response to be mimicked inE. coli:1.Generation of a highly complex antibody repertoire;2.Clonal selection procedures for library screening; and3.The possibility of increasing a given affinity by repeated rounds of mutation and selection.


Archive | 1992

Phagemide for screening antibodies

Frank Breitling; Melvyn Little; Stefan Dübels; Michael Braunagel; Iris Klewinghaus


Gene | 1992

A vector for the removal of deletion mutants from antibody libraries

Thomas Dr Seehaus; Frank Breitling; Stefan Dübel; Iris Klewinghaus; Melvyn Little


Archive | 1994

Preparation and use of gene banks of synthetic human antibodies ("synthetic human-antibody libraries")

Melvyn Little; Frank Breitling; Thomas Dr Seehaus; Stefan Dübel; Iris Klewinghaus


Archive | 1992

Phagemid for antibody screening

Frank Breitling; Melvyn Little; Stefan Dübel; Michael Braunagel; Iris Klewinghaus


Archive | 1991

Preparation and use of gene banks of human antibodies ("human-antibody libraries")

Melvyn Little; Frank Breitling; Thomas Dr Seehaus; Stefan Dübel; Iris Klewinghaus


Archive | 1999

Phagemid library for antibody screening

Frank Breitling; Melvyn Little; Stefan Dübel; Michael Braunagel; Iris Klewinghaus

Collaboration


Dive into the Iris Klewinghaus's collaboration.

Top Co-Authors

Avatar

Melvyn Little

German Cancer Research Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Thomas Dr Seehaus

German Cancer Research Center

View shared research outputs
Top Co-Authors

Avatar

Michael Braunagel

German Cancer Research Center

View shared research outputs
Top Co-Authors

Avatar

Stefan Dübel

Braunschweig University of Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Stefan Dübel

Braunschweig University of Technology

View shared research outputs
Top Co-Authors

Avatar

Patrick Fuchs

German Cancer Research Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge